Skip to main content

Cingulate begins Phase 3 tests of novel treatment for ADHD

Cingulate's technology will let patients receive treatment ADHD treatment without second doses, boosters to get through the day.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.